YL-18319

N/A

Report date: 2026/04/30 13:52:50
NME

Base Information

Drug NameYL-18319
Drug Alias NameYL-18319
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors
TargetsPoly(ADP-ribose) glycohydrolase
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYL-Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYL-Pharma
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A